CYCC Bio Green Med Solution Inc.


$ 5.49 $ -0.14 (-2.49 %)    

Wednesday, 15-Oct-2025 12:19:03 EDT
QQQ $ 602.95 $ -0.86 (-0.14 %)
DIA $ 463.68 $ -0.96 (-0.21 %)
SPY $ 665.50 $ -1.26 (-0.19 %)
TLT $ 90.68 $ -0.28 (-0.31 %)
GLD $ 386.26 $ 0.30 (0.08 %)
$ 5.87
$ 6.00
$ 5.40 x 100
$ 5.60 x 42
$ 5.41 - $ 6.00
$ 3.08 - $ 283.40
568,505
na
na
$ 1.38
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cyclacel-pharmaceuticals-exchanges-series-c-warrants-for-559395-common-shares-in-agreement-with-accredited-investors

On September 4, 2025, Cyclacel Pharmaceuticals, Inc. (the "Company") entered into a Warrant Exchange Agreement (the ...

 cyclacel-pharmaceuticals-stock-up-346-in-massive-after-hours-rally

After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 3...

 reported-earlier-cyclacel-announces-new-findings-supporting-use-of-plogosertib-in-biliary-tract-cancer-patients-with-high-bubr1-expression

  Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION